𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targets for the therapeutic action of interferon-β in multiple sclerosis

✍ Scribed by Hans-Peter Hartung; Bernd C. Kieseier

Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
241 KB
Volume
40
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identify of interferon-β1a product in mu
Identify of interferon-β1a product in multiple sclerosis study
✍ Wieland W. Wolf 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

We extend sincere congratulations to Dr Jacobs and colleagues for the successful conclusion of their study of recombinant interferon p l a (rIFN-pla) in patients with multiple sclerosis (MS). The impressive results showed that 6 million international units of rIFN-Pla applied once weekly via the int

Real-life impact of early interferonβ th
Real-life impact of early interferonβ therapy in relapsing multiple sclerosis
✍ M. Trojano; F. Pellegrini; D. Paolicelli; A. Fuiani; G.B. Zimatore; C. Tortorell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

## Abstract ## Objective Recent findings support greater efficacy of early vs. delayed interferon beta (IFNβ) treatment in patients with a first clinical event suggestive of multiple sclerosis (MS). We aimed to evaluate the effectiveness of early IFNβ treatment in definite relapsing‐remitting MS (